Spectral Precise Image Study for Brain Tumors

Clinical Study for Exploring Image Quality the Spectral Precise Image in Patients With Diagnosed Intracranial Tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07620470

Enrollment

120

Registered

2026-06-02

Start date

2025-11-28

Completion date

2026-12-31

Last updated

2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumors

Brief summary

The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors. The main question it aims to answer is: The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions

Interventions

DEVICEThis is an observational data collection study

This is an observational data collection study

Study design

Observational model

CASE_ONLY

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Patients with clinical and radiology (MRI/CT) diagnosed brain tumors. 2. Patients who underwent contrast enhanced scans using the Spectral CT 7500. 3. Study participants with age ≥ 18 years old. 4. Study participants that have signed Informed Consent Form (ICF)

Exclusion criteria

1. The clinical data or radiological information is considered incomplete after evaluation by the investigator. 2. Study participant that was enrolled in this study in the past 3. Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation

Design outcomes

Primary

Measure	Time frame	Description
Subjective Image quality using Likert score (1-5)	From date of image reconstruction until the date of image reading completion, anticipated 3Months.	Image quality will be assessed by 2 radiologists using Likert score on a scale ranging from 1(poor) to 5(Excellent)
Objective Image Quality	From date of image reconstruction until the date of image reading completion, anticipated 3Months.	The objective quality of the image is evaluated by measuring the CT value shown in the image.

Countries

China

Contacts

CONTACTJing Wang

xhwangjing@hust.edu.cn+8613986085216

PRINCIPAL_INVESTIGATORJing Wang

1277 Jiefang Avenue, Wuhan, Hubei Province, P. R. China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026